NSE · SRPL
Shree Ram Proteins Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹3 Cr with net profit ₹-21 Cr — a -825.18% net margin, versus -63.44% the period before.
Shareholding
As of 2026-03-31
- Promoter4.08%
- Public91.49%
- FII4.44%
41,448 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.21× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Solvent Extraction · ranked #25 of 30 by market cap · medians across 26 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Marico Limited | ₹1,14,089 Cr | 289.05 | 27.09 | 41.85% | 12.95% |
| Patanjali Foods Limited | ₹38,862 Cr | 74.1 | 2.96 | 15.37% | 4.52% |
| AWL Agri Business Limited | ₹24,682 Cr | 84.03 | 2.35 | 9.98% | 1.39% |
| Gokul Agro Resources Ltd. | ₹6,586 Cr | 55.38 | 2.31 | 25.96% | 1.53% |
| CIAN Agro Industries & Infrastructure Ltd. | ₹3,980 Cr | 17.87 | 1.88 | 10.34% | 10.05% |
| Avt Natural Products Ltd. | ₹1,066 Cr | 48.26 | 1.91 | 11.59% | 9.09% |
| Shri Venkatesh Refineries Ltd. | ₹896 Cr | 23.45 | 7.51 | 29.06% | 2.49% |
| Modi Naturals Limited | ₹536 Cr | 26.87 | 3.13 | 29.21% | 6.99% |
| KN Agri Resources Limited | ₹524 Cr | 16.54 | 1.36 | 8.23% | 1.75% |
| Kriti Nutrients Limited | ₹362 Cr | 10.86 | 1.58 | 14.8% | 3.68% |
| Shree Ram Proteins Ltd.(this company) | ₹8 Cr | -0.68 | 0.38 | -29.14% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashShree Ram Proteins Ltd. (SRPL) has a market capitalization of Rs 8 Cr. The company reported revenue of Rs 2.55 Cr and a profit margin of 0%. Its debt-to-equity ratio stands at 1.04. The 52-week high for the share price was Rs 0.84 and the 52-week low was Rs 0.38.
Positives
- +No promoter shares are pledged, with a promoter pledge of 0% as of Mar 2026.
Negatives
- −The company's revenue has significantly declined from Rs 162.73 Cr in Mar 2023 to Rs 2.55 Cr in Mar 2025.
- −Shree Ram Proteins Ltd. reported a net loss of Rs -21.08 Cr in Mar 2025, down from a net profit of Rs 3.84 Cr in Mar 2023.
- −The company has negative returns on equity (ROE) at -29.14% and capital employed (ROCE) at -9.82%.
- −Promoter holding is low at 4.08% as of Mar 2026.
- −The debt-to-equity ratio of 1.04 indicates higher debt relative to equity.
Financial Performance
Shree Ram Proteins Ltd. has experienced a significant decline in its financial performance. Revenue decreased from Rs 162.73 Cr in Mar 2023 to Rs 2.55 Cr in Mar 2025. Net profit also saw a decline, moving from Rs 3.84 Cr in Mar 2023 to a net loss of Rs -21.08 Cr in Mar 2025. Earnings per share (EPS) declined from Rs 1.79 in Mar 2023 to Rs -0.98 in Mar 2025.
Profitability & Returns
The company’s profitability metrics indicate challenges. The return on equity (ROE) for Shree Ram Proteins Ltd. was -29.14% and the return on capital employed (ROCE) was -9.82% as of the latest available data. The profit margin is 0%. These figures reflect negative returns generated on both equity and capital employed.
Balance Sheet
As of the latest data, Shree Ram Proteins Ltd. has a book value per share of Rs 0.87. The company's debt-to-equity ratio is 1.04. This indicates that for every rupee of equity, the company has Rs 1.04 of debt. There is no information available regarding pledges on promoter shares.
Ownership & Pledges
As of March 31, 2026, the promoter holding in Shree Ram Proteins Ltd. was 4.08%. Public shareholding was 91.49%, and FIIs held 4.44%. The number of shareholders as of March 31, 2026, was 41,448. There were no promoter shares reported as pledged.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.